Lantern Pharma (LTRN) Reports Q1 Loss of $0.51

May 9, 2024 4:45 PM

Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.51).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.